Literature DB >> 17591592

Renal cell cancer and body size at different ages: an Italian multicenter case-control study.

Luigino Dal Maso1, Antonella Zucchetto, Alessandra Tavani, Maurizio Montella, Valerio Ramazzotti, Renato Talamini, Vincenzo Canzonieri, Antonio Garbeglio, Eva Negri, Annamaria Tonini, Carlo La Vecchia, Silvia Franceschi.   

Abstract

An increased risk of renal cell cancer (RCC) has been reported in overweight persons. The authors aimed to clarify which anthropometric measures are associated with risk of RCC and whether risk may vary according to selected variables. Between 1992 and 2004, they carried out an Italian multicenter case-control study including 767 (494 men, 273 women) incident cases of RCC and 1,534 hospital controls, frequency-matched to cases. To estimate odds ratios and 95% confidence intervals, they used conditional logistic regression matched on study center, sex, and age and adjusted for period of interview, years of education, smoking habits, and family history of kidney cancer. Using body-size measurements taken 1 year prior to diagnosis/interview, the authors found an odds ratio of 1.3 (95% confidence interval (CI): 1.0, 1.7) among obese persons (body mass index (BMI; weight (kg)/height (m)(2)) > or =30) versus normal-weight persons (BMI <25) and an odds ratio of 1.5 (95% CI: 1.1, 2.0) among persons in the highest tertile of waist-to-hip ratio. Direct associations emerged for BMI > or =30 (vs. <25) at ages 30 years (odds ratio = 1.5, 95% CI: 1.0, 2.3) and 50 years (odds ratio = 1.5, 95% CI: 1.1, 2.0). The direct association with waist-to-hip ratio was stronger among women than among men. RCC risks among overweight and obese persons were apparently higher in never smokers, persons with the clear-cell histologic type, and persons with a Fuhrman nuclear grade of G3-G4.

Entities:  

Mesh:

Year:  2007        PMID: 17591592     DOI: 10.1093/aje/kwm108

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

1.  Preoperative outpatient blood pressure variability predicts postoperative mortality, readmission and morbidity after surgery.

Authors:  Marc D Basson; Marilyn G Klug; William E Newman; Cornelius Dyke
Journal:  Am J Surg       Date:  2020-02-27       Impact factor: 2.565

2.  Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.

Authors:  Catherine L Callahan; Jonathan N Hofmann; Douglas A Corley; Wei K Zhao; Brian Shuch; Wong-Ho Chow; Mark P Purdue
Journal:  Cancer Epidemiol       Date:  2018-07-18       Impact factor: 2.984

3.  Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgery.

Authors:  Bruce R Kava; Ahmed Eldefrawy; Rajinikanth Ayyathurai; Murugesan Manoharan; Mohamed Aziz; Vincent G Bird; Devendar Katkoori; Rajan Ramanathan; Merce Jorda; Gaetano Ciancio; Mark S Soloway; Raymond J Leveillee
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

Review 4.  Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk.

Authors:  Bernard F Fuemmeler; Margaret K Pendzich; Kenneth P Tercyak
Journal:  Obes Facts       Date:  2009-06-04       Impact factor: 3.942

5.  An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.

Authors:  Mark P Purdue; Lee E Moore; Maria J Merino; Paolo Boffetta; Joanne S Colt; Kendra L Schwartz; Vladimir Bencko; Faith G Davis; Barry I Graubard; Vladimir Janout; Julie J Ruterbusch; Jennifer Beebe-Dimmer; Michele L Cote; Brian Shuch; Dana Mates; Jonathan N Hofmann; Lenka Foretova; Nathaniel Rothman; Neonilia Szeszenia-Dabrowska; Vsevolod Matveev; Sholom Wacholder; David Zaridze; W Marston Linehan; Paul Brennan; Wong-Ho Chow
Journal:  Int J Cancer       Date:  2013-01-15       Impact factor: 7.396

6.  Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

Authors:  Xiang Shu; Jie Lin; Christopher G Wood; Nizar M Tannir; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2013-02-02       Impact factor: 13.506

7.  Body mass index and renal cell cancer: the influence of race and sex.

Authors:  Jennifer L Beebe-Dimmer; Joanne S Colt; Julie J Ruterbusch; Gregory R Keele; Mark P Purdue; Sholom Wacholder; Barry I Graubard; Faith Davis; Wong-Ho Chow; Kendra L Schwartz
Journal:  Epidemiology       Date:  2012-11       Impact factor: 4.822

8.  Body size and renal cell cancer incidence in a large US cohort study.

Authors:  Kenneth F Adams; Michael F Leitzmann; Demetrius Albanes; Victor Kipnis; Steven C Moore; Arthur Schatzkin; Wong-Ho Chow
Journal:  Am J Epidemiol       Date:  2008-06-09       Impact factor: 4.897

9.  Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.

Authors:  William T Lowrance; R Houston Thompson; David S Yee; Matthew Kaag; S Machele Donat; Paul Russo
Journal:  BJU Int       Date:  2009-07-06       Impact factor: 5.588

10.  A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.

Authors:  Xifeng Wu; Ghislaine Scelo; Mark P Purdue; Nathaniel Rothman; Mattias Johansson; Yuanqing Ye; Zhaoming Wang; Diana Zelenika; Lee E Moore; Christopher G Wood; Egor Prokhortchouk; Valerie Gaborieau; Kevin B Jacobs; Wong-Ho Chow; Jorge R Toro; David Zaridze; Jie Lin; Jan Lubinski; Joanna Trubicka; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Viorel Jinga; Vladimir Bencko; Alena Slamova; Ivana Holcatova; Marie Navratilova; Vladimir Janout; Paolo Boffetta; Joanne S Colt; Faith G Davis; Kendra L Schwartz; Rosamonde E Banks; Peter J Selby; Patricia Harnden; Christine D Berg; Ann W Hsing; Robert L Grubb; Heiner Boeing; Paolo Vineis; Françoise Clavel-Chapelon; Domenico Palli; Rosario Tumino; Vittorio Krogh; Salvatore Panico; Eric J Duell; José Ramón Quirós; Maria-José Sanchez; Carmen Navarro; Eva Ardanaz; Miren Dorronsoro; Kay-Tee Khaw; Naomi E Allen; H Bas Bueno-de-Mesquita; Petra H M Peeters; Dimitrios Trichopoulos; Jakob Linseisen; Börje Ljungberg; Kim Overvad; Anne Tjønneland; Isabelle Romieu; Elio Riboli; Victoria L Stevens; Michael J Thun; W Ryan Diver; Susan M Gapstur; Paul D Pharoah; Douglas F Easton; Demetrius Albanes; Jarmo Virtamo; Lars Vatten; Kristian Hveem; Tony Fletcher; Kvetoslava Koppova; Olivier Cussenot; Geraldine Cancel-Tassin; Simone Benhamou; Michelle A Hildebrandt; Xia Pu; Mario Foglio; Doris Lechner; Amy Hutchinson; Meredith Yeager; Joseph F Fraumeni; Mark Lathrop; Konstantin G Skryabin; James D McKay; Jian Gu; Paul Brennan; Stephen J Chanock
Journal:  Hum Mol Genet       Date:  2011-10-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.